Loading stock data…
$1.33+0.01 (+0.38%)
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. in the Healthcare sector is trading at $1.33 with a market capitalization of $6M. The stock is currently near its 52-week low of $0.85, remaining 37.9% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $6.41M↑ | $5.56M↑ | $4.35M↓ | $5.60M↑ | $4.01M |
| Gross Profit | $2.58M↑ | $2.18M↑ | $1.65M↓ | $2.12M↑ | $1.46M |
| Operating Income | -$40,000↑ | -$351,000↑ | -$678,000↓ | -$337,000↑ | -$1.09M |
| Net Income | -$330,000↑ | -$581,000↑ | -$819,000↓ | -$534,000↑ | -$1.24M |
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America...